Toxoplasma gondii

References

• Cenci-Goga BT, Rossitto PV, Sechi P, McCrindle CM, Cullor JS. Toxoplasma in animals, food, and humans: an old parasite of new concern. Foodborne Pathog Dis 2011; 8:751 - 62; http://dx.doi.org/10.1089/fpd.2010.0795; PMID: 21486145
   PubMed Web of Science ®Google Scholar
• Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet Res 1998; 29:289 - 310; PMID: 9689743
   PubMed Web of Science ®Google Scholar
• Stanford MR, Gilbert RE. Treating ocular toxoplasmosis: current evidence. Mem Inst Oswaldo Cruz 2009; 104:312 - 5; http://dx.doi.org/10.1590/S0074-02762009000200027; PMID: 19430659
   PubMed Web of Science ®Google Scholar
• Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011; 239:62 - 84; http://dx.doi.org/10.1111/j.1600-065X.2010.00980.x; PMID: 21198665
   PubMed Web of Science ®Google Scholar
• Denkers EY, Bzik DJ, Fox BA, Butcher BA. An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.. Infect Immun 2012; 80:476 - 82; http://dx.doi.org/10.1128/IAI.05974-11; PMID: 22104110
   PubMed Web of Science ®Google Scholar
• Ferguson DJ, Jacobs D, Saman E, Dubremetz JF, Wright SE. In vivo expression and distribution of dense granule protein 7 (GRA7) in the exoenteric (tachyzoite, bradyzoite) and enteric (coccidian) forms of Toxoplasma gondii. Parasitology 1999; 119:259 - 65; http://dx.doi.org/10.1017/S0031182099004692; PMID: 10503251
   PubMed Web of Science ®Google Scholar
• Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012; 11:189 - 209; http://dx.doi.org/10.1586/erv.11.188; PMID: 22309668
   PubMed Web of Science ®Google Scholar
• Zhang P, Martin M, Yang QB, Michalek SM, Katz J. Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis.. Infect Immun 2004; 72:637 - 44; http://dx.doi.org/10.1128/IAI.72.2.637-644.2004; PMID: 14742503
   PubMed Web of Science ®Google Scholar
• Garidou L, Heydari S, Truong P, Brooks DG, McGavern DB. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. J Virol 2009; 83:8905 - 15; http://dx.doi.org/10.1128/JVI.00027-09; PMID: 19553326
   PubMed Web of Science ®Google Scholar
• Boesteanu AC, Katsikis PD. Memory T cells need CD28 costimulation to remember. Semin Immunol 2009; 21:69 - 77; http://dx.doi.org/10.1016/j.smim.2009.02.005; PMID: 19268606
   PubMed Web of Science ®Google Scholar
• Santra S, Barouch DH, Jackson SS, Kuroda MJ, Schmitz JE, Lifton MA, Sharpe AH, Letvin NL. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. J Immunol 2000; 165:6791 - 5; PMID: 11120800
   PubMed Web of Science ®Google Scholar
• Maue AC, Waters WR, Palmer MV, Whipple DL, Minion FC, Brown WC, Estes DM. CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis. Vaccine 2004; 23:769 - 79; http://dx.doi.org/10.1016/j.vaccine.2004.07.019; PMID: 15542201
   PubMed Web of Science ®Google Scholar
• Duttagupta PA, Boesteanu AC, Katsikis PD. Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol 2009; 29:469 - 86; http://dx.doi.org/10.1615/CritRevImmunol.v29.i6.20; PMID: 20121696
   PubMed Web of Science ®Google Scholar
• Subauste CS, de Waal Malefyt R, Fuh F. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen. J Immunol 1998; 160:1831 - 40; PMID: 9469444
   PubMed Web of Science ®Google Scholar
• Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB. Development of a multicomponent candidate vaccine for HIV-1. Vaccine 1997; 15:879 - 83; http://dx.doi.org/10.1016/S0264-410X(96)00260-5; PMID: 9234538
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 1997; 158:4591 - 601; PMID: 9144471
   PubMed Web of Science ®Google Scholar
• Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, et al. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J Immunol 1999; 162:3417 - 27; PMID: 10092797
   PubMed Web of Science ®Google Scholar
• Verma R, Khanna P. Development of Toxoplasma gondii vaccine: A global challenge. Hum Vaccin Immunother 2012; 9:291 - 3; http://dx.doi.org/10.4161/hv.22474; PMID: 23111123
   PubMed Web of Science ®Google Scholar
• Mévélec MN, Bout D, Desolme B, Marchand H, Magné R, Bruneel O, Buzoni-Gatel D. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005; 23:4489 - 99; http://dx.doi.org/10.1016/j.vaccine.2005.04.025; PMID: 15935521
   PubMed Web of Science ®Google Scholar
• Quan JH, Chu JQ, Ismail HA, Zhou W, Jo EK, Cha GH, Lee YH. Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii.. Clin Vaccine Immunol 2012; 19:666 - 74; http://dx.doi.org/10.1128/CVI.05385-11; PMID: 22419676
   PubMed Web of Science ®Google Scholar
• Liu Q, Singla LD, Zhou H. Vaccines against Toxoplasma gondii: status, challenges and future directions. Hum Vaccin Immunother 2012; 8:1305 - 8; http://dx.doi.org/10.4161/hv.21006; PMID: 22906945
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Zhang XX, He XH, Petersen E, Zhou DH, He Y, Lin RQ, Li XZ, Chen XL, Shi XR, et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin Vaccine Immunol 2011; 18:119 - 24; http://dx.doi.org/10.1128/CVI.00312-10; PMID: 21106780
   PubMed Web of Science ®Google Scholar
• Hiszczyńska-Sawicka E, Olędzka G, Holec-Gąsior L, Li H, Xu JB, Sedcole R, Kur J, Bickerstaffe R, Stankiewicz M. Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Vet Parasitol 2011; 177:281 - 9; http://dx.doi.org/10.1016/j.vetpar.2010.11.047; PMID: 21251760
   PubMed Web of Science ®Google Scholar
• Jongert E, de Craeye S, Dewit J, Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 2007; 29:445 - 53; http://dx.doi.org/10.1111/j.1365-3024.2007.00961.x; PMID: 17727568
   PubMed Web of Science ®Google Scholar
• Min J, Qu D, Li C, Song X, Zhao Q, Li XA, Yang Y, Liu Q, He S, Zhou H. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy. Vaccine 2012; 30:5631 - 6; http://dx.doi.org/10.1016/j.vaccine.2012.06.081; PMID: 22789504
   PubMed Web of Science ®Google Scholar
• Ismail N, Olano JP, Feng HM, Walker DH. Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol Lett 2002; 207:111 - 20; http://dx.doi.org/10.1111/j.1574-6968.2002.tb11038.x; PMID: 11958927
   PubMed Web of Science ®Google Scholar
• Foulds KE, Wu CY, Seder RA. Th1 memory: implications for vaccine development. Immunol Rev 2006; 211:58 - 66; http://dx.doi.org/10.1111/j.0105-2896.2006.00400.x; PMID: 16824117
   PubMed Web of Science ®Google Scholar
• Jongert E, Lemiere A, Van Ginderachter J, De Craeye S, Huygen K, D’Souza S. Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells. Vaccine 2010; 28:2556 - 64; http://dx.doi.org/10.1016/j.vaccine.2010.01.031; PMID: 20117266
   PubMed Web of Science ®Google Scholar
• Tighe H, Corr M, Roman M, Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 1998; 19:89 - 97; http://dx.doi.org/10.1016/S0167-5699(97)01201-2; PMID: 9509764
   PubMedGoogle Scholar
• Qu D, Han J, Du A. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitol Res 2013; 112:2593 - 9; http://dx.doi.org/10.1007/s00436-013-3425-0; PMID: 23591483
   PubMed Web of Science ®Google Scholar
• Zhou H, Min J, Zhao Q, Gu Q, Cong H, Li Y, He S. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine 2012; 30:1800 - 6; http://dx.doi.org/10.1016/j.vaccine.2012.01.004; PMID: 22240340
   PubMed Web of Science ®Google Scholar
• Nagaraju K. Immunological capabilities of skeletal muscle cells. Acta Physiol Scand 2001; 171:215 - 23; http://dx.doi.org/10.1046/j.1365-201x.2001.00823.x; PMID: 11412133
   PubMedGoogle Scholar
• Wiendl H, Hohlfeld R, Kieseier BC. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol 2005; 26:373 - 80; http://dx.doi.org/10.1016/j.it.2005.05.003; PMID: 15922662
   PubMed Web of Science ®Google Scholar
• Shirota H, Petrenko L, Hong C, Klinman DM. Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity. J Immunol 2007; 179:329 - 36; PMID: 17579053
   PubMed Web of Science ®Google Scholar
• Sibley LD, Ajioka JW. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu Rev Microbiol 2008; 62:329 - 51; http://dx.doi.org/10.1146/annurev.micro.62.081307.162925; PMID: 18544039
   PubMed Web of Science ®Google Scholar
• Rashid I, Hedhli D, Moiré N, Pierre J, Debierre-Grockiego F, Dimier-Poisson I, Mévélec MN. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis. Vaccine 2011; 29:8838 - 46; http://dx.doi.org/10.1016/j.vaccine.2011.09.099; PMID: 21983362
   PubMed Web of Science ®Google Scholar